THE TREATMENT OF DEEP VEIN THROMBOSIS WITH CONTINUOUS INTRAVENOUS LOW-MOLECULAR-WEIGHT DERMATAN SULPHATE (DESMIN). A PILOT STUDY

By Kretz J.-G.   Chakfe N.   Wiesel M.-L.   Grunebaum L.   Zamboni V.   Palazzini E.   Cazenave J.-P.  

Thrombosis Research, Vol. 84, Iss. 6, 1996-12 ,pp. : 391-398

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of Low Molecular Weight Dermatan Sulphate (Desmin) in Different Cohorts of Patients - An interactive graphic program for individual and population pharmacokinetic parameters estimation

By Saivin S.   Carrie D.   Escourrou J.   Duchene P.   Zamboni V.   Barbanti M.   Palazzini E.   Houin G.  

Thrombosis Research, Vol. 90, Iss. 3, 1998-05 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite

Pharmacology of Desmin (low molecular weight Dermatan sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg)

By Dettori A.G.   Milani M.R.   Manotti C.   Zamboni V.   Palazzini E.   Barbanti M.  

Thrombosis Research, Vol. 79, Iss. 3, 1995-08 ,pp. : 249-260

Elsevier

Access to resources Recommend Favorite

PHARMACOLOGY OF A NEW LOW MOLECULAR WEIGHT DERMATAN SULPHATE (DESMIN) IN HEALTHY VOLUNTEERS: REPEATED DAILY INTRAMUSCULAR ADMINISTRATION OF 400 mg FOR A WEEK

By Dettori A.G.   Zamboni V.   Manotti C.   Canova N.   Barbanti M.   Palazzini E.  

Thrombosis Research, Vol. 83, Iss. 1, 1996-07 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite

ACTIVE SITE FOR HEPARIN COFACTOR II IN LOW MOLECULAR MASS DERMATAN SULFATE. CONTRIBUTION TO THE ANTITHROMBOTIC ACTIVITY OF FRACTIONS WITH HIGH AFFINITY FOR HEPARIN COFACTOR II

By Mascellani G.   Liverani L.   Parma B.   Bergonzini G.   Bianchini P.  

Thrombosis Research, Vol. 84, Iss. 1, 1996-10 ,pp. : 21-32

Elsevier

Access to resources Recommend Favorite